Venkatesh Pilla Reddy
Senior Director, Global PKPD & Pharmacometrics Eli Lilly & Co.
Venkatesh currently serves as Senior Director, Global PKPD and Pharmacometrics at Eli Lilly & Co. He is a highly motivated clinical pharmacologist and pharmacometrics leader with track record in clinical drug development, pharmacometrics, clinical pharmacology, translational sciences, DMPK, regulatory submissions. Venkatesh specialises in ability to forge productive internal and external collaborations, mentoring/ leading high-performing scientific teams with a focus to promote and apply innovative methods to maximise data use for trial efficiency in both early and late stages of drug development.
Seminars
Join the clinical and medical presenters to review the key learnings from the scientific programme days. Be sure to bring any questions across ADC clinical development strategy, dose escalation, biomarker-driven development, and ADC sequencing.
Navigating dose escalation and selection is a crucial stage in early development to set up ADC performance for success under Project Optimus guidelines
Don’t miss this Eli Lilly-led workshop to delve into all things ADC clinical pharmacology across quantitative systems pharmacology and clinical utility index approaches to optimise your ADC dose selection
Workshop highlights include:
- Utilising quantitative systems pharmacology to investigate ADC preclinical PK/PD characterisation
- Leveraging clinical utility index approach to assess the benefit-risk profiles of ADCs
- Understanding ADC-specific clinical pharmacology considerations and assessing lessons learnt from ADC dose capping
